Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Gartex Texprocess India to showcase innovations across textile ecosystem- Figure out How to Augment the Advantages of a Web-based Degree
- Artemis II astronauts channel Apollo 8 with a striking Earthset photo
- Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
- Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
- The Most Encouraging New companies to Look Out For
- Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
- 5 Home EV Chargers for Proficient and Solid Charging
- Cyber Monday 2025 streaming deal: Get $42 off six months of Apple TV
